PT993439E
(pt)
|
1997-07-01 |
2004-12-31 |
Warner Lambert Co |
Derivados de acido 4-bromo ou 4-iodofenilaminobenzidroxamico e sua utilizacao como inibidores de mek
|
US5932580A
(en)
|
1997-12-01 |
1999-08-03 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds their preparation and compositions
|
IL139080A0
(en)
|
1998-04-17 |
2001-11-25 |
Parker Hughes Inst |
Btx inhibitors and methods for their indentification and use
|
ES2190221T3
(es)
|
1998-05-04 |
2003-07-16 |
Zentaris Ag |
Derivados de indol y su uso para el tratamiento de enfermedades malignas y otras, que se basan en proliferaciones celulares patologicas.
|
EP1144371B1
(en)
|
1999-01-13 |
2005-11-09 |
Warner-Lambert Company Llc |
Benzenesulphonamide derivatives and their use as mek inhibitors
|
WO2000042022A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzoheterocycles and their use as mek inhibitors
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
BR9916894A
(pt)
|
1999-01-13 |
2001-11-20 |
Warner Lambert Co |
ácidos sulfohidroxâmicos e sulfohidroxamatos eseu uso como inibidores de mek
|
AU3761400A
(en)
|
1999-03-19 |
2000-10-09 |
Du Pont Pharmaceuticals Company |
Amino-thio-acrylonitriles as mek inhibitors
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
US8137695B2
(en)
|
2006-08-18 |
2012-03-20 |
Arrowhead Madison Inc. |
Polyconjugates for in vivo delivery of polynucleotides
|
ES2237430T3
(es)
|
1999-06-09 |
2005-08-01 |
Yamanouchi Pharmaceutical Co. Ltd. |
Nuevos derivados carboxamida heterociclicos.
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
ES2225231T3
(es)
|
1999-10-06 |
2005-03-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compuestos heterociclicos, utiles como inhibidores de tirosina quinasas.
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
OA12514A
(en)
|
1999-12-24 |
2006-05-29 |
Aventis Pharma Ltd |
Azaindoles.
|
WO2001052892A2
(en)
|
2000-01-24 |
2001-07-26 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the uses thereof
|
ATE369359T1
(de)
|
2000-02-15 |
2007-08-15 |
Sugen Inc |
Pyrrol substituierte indolin-2-on protein kinase inhibitoren
|
US7087608B2
(en)
|
2000-03-03 |
2006-08-08 |
Robert Charles Atkins |
Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
|
JP2003527379A
(ja)
|
2000-03-15 |
2003-09-16 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
Mex阻害物質としての5−アミド置換ジアリールアミン類
|
AR035851A1
(es)
|
2000-03-28 |
2004-07-21 |
Wyeth Corp |
3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
DE10017480A1
(de)
|
2000-04-07 |
2001-10-11 |
Transmit Technologietransfer |
Verwendung von Substanzen, die als MEK Inhibitor wirken, zur Herstellung eines Arneimittels gegen DNA- und RNA-Viren
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
WO2002069960A2
(en)
|
2001-03-06 |
2002-09-12 |
Axxima Pharmaceuticals Ag |
Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock
|
ATE427948T1
(de)
|
2001-04-24 |
2009-04-15 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
TWI238824B
(en)
|
2001-05-14 |
2005-09-01 |
Novartis Ag |
4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
|
JP2005500041A
(ja)
|
2001-06-29 |
2005-01-06 |
アブ サイエンス |
強力で選択的かつ非毒性のc−kit阻害剤
|
JP2004530730A
(ja)
|
2001-06-29 |
2004-10-07 |
アブ サイエンス |
腫瘍の血管新生を治療するための強力で選択的かつ非毒性のc−kit阻害剤の使用法
|
WO2003002114A2
(en)
|
2001-06-29 |
2003-01-09 |
Ab Science |
Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
|
EP1450775B1
(en)
|
2001-09-20 |
2008-03-12 |
AB Science |
C-kit inhibitors for treating bacterial infections
|
WO2003027111A1
(en)
|
2001-09-27 |
2003-04-03 |
Smithkline Beecham Corporation |
Chemical compounds
|
US20030158195A1
(en)
|
2001-12-21 |
2003-08-21 |
Cywin Charles L. |
1,6 naphthyridines useful as inhibitors of SYK kinase
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
US20030216460A1
(en)
|
2002-03-13 |
2003-11-20 |
Wallace Eli M. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
KR100984613B1
(ko)
|
2002-03-13 |
2010-09-30 |
어레이 바이오파마 인크. |
Mek 억제제로서의 n3 알킬화 벤즈이미다졸 유도체
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
JP2005527523A
(ja)
|
2002-03-15 |
2005-09-15 |
ノバルティス アクチエンゲゼルシャフト |
AngII介在性疾病を処置するための4−(4−メチルピペラジン−1−イルメチル)−N−[4−メチル−3−(4−ピリジン−3−イル)ピリミジン−2−イル−アミノ]フェニル]−ベンズアミド
|
RU2004135386A
(ru)
|
2002-05-06 |
2005-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Тиадиазолы или оксадиазолы и их применение в качестве ингибиторов протеинкиназы jak
|
EP1507779A1
(en)
|
2002-05-30 |
2005-02-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of jak and cdk2 protein kinases
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
WO2004011461A1
(en)
|
2002-07-25 |
2004-02-05 |
Pfizer Products Inc. |
Isothiazole derivatives useful as anticancer agents
|
ES2294344T3
(es)
|
2002-08-02 |
2008-04-01 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazoles y su utilizacion como inhibidores de c-kit.
|
ATE454378T1
(de)
|
2002-11-01 |
2010-01-15 |
Vertex Pharma |
Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen
|
ES2289349T3
(es)
|
2002-11-04 |
2008-02-01 |
Vertex Pharmaceuticals Incorporated |
Derivados de heteroaril-pirimidina como inhibidores de jak.
|
JP2006508107A
(ja)
|
2002-11-05 |
2006-03-09 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Jakおよび他のプロテインキナーゼのインヒビターとして有用な化合物
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
US7994159B2
(en)
|
2003-03-10 |
2011-08-09 |
Eisai R&D Management Co., Ltd. |
c-Kit kinase inhibitor
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
US7872014B2
(en)
|
2003-07-23 |
2011-01-18 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
MXPA06001110A
(es)
|
2003-08-01 |
2006-04-11 |
Wyeth Corp |
Uso de una combinacion de un inhibidor de la cinasa del receptor del factor de crecimiento epidermico y agentes citotoxicos para el tratamiento e inhibicion del cancer.
|
BRPI0413616B8
(pt)
|
2003-08-15 |
2021-05-25 |
Irm Llc |
2,4-pirimidinadiaminas, seus usos, e composição farmacêutica
|
BRPI0413785A
(pt)
|
2003-08-21 |
2006-11-07 |
Osi Pharm Inc |
composto, composição, e, método de tratamento de distúrbio hiperproliferativo
|
BRPI0413740A
(pt)
|
2003-08-21 |
2006-10-24 |
Osi Pharm Inc |
composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo
|
EP1664021A1
(en)
|
2003-08-21 |
2006-06-07 |
OSI Pharmaceuticals, Inc. |
N-substituted benzimidazolyl c-kit inhibitors
|
US7144907B2
(en)
|
2003-09-03 |
2006-12-05 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
US7538120B2
(en)
|
2003-09-03 |
2009-05-26 |
Array Biopharma Inc. |
Method of treating inflammatory diseases
|
DE10342794A1
(de)
|
2003-09-16 |
2005-04-21 |
Basf Ag |
Sekretion von Proteinen aus Hefen
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
WO2005028426A1
(ja)
|
2003-09-19 |
2005-03-31 |
Chugai Seiyaku Kabushiki Kaisha |
新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
|
BRPI0414698A
(pt)
|
2003-09-23 |
2006-11-28 |
Novartis Ag |
combinação de um inibidor receptor de vegf com um agente quimioterapêutico
|
RU2405784C2
(ru)
|
2003-10-15 |
2010-12-10 |
Оси Фармасьютикалз, Инк. |
Имидазопиразины в качестве ингибиторов тирозинкиназ
|
EP1526177A1
(en)
|
2003-10-24 |
2005-04-27 |
Institut Curie |
Nucleic acids useful for triggering tumor cell lethality
|
US7476729B2
(en)
|
2003-10-24 |
2009-01-13 |
Institut Curie |
Dbait and uses thereof
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
MXPA06005657A
(es)
|
2003-11-19 |
2006-08-23 |
Array Biopharma Inc |
Inhibidores heterociclicos de mek y metodos para usarlos.
|
DE102004001607A1
(de)
|
2004-01-09 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
|
WO2005073225A1
(en)
|
2004-01-30 |
2005-08-11 |
Ab Science |
2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
|
TW200538097A
(en)
|
2004-02-27 |
2005-12-01 |
Eisai Co Ltd |
Novel pyridine derivative and pyrimidine derivative
|
DK2332940T3
(da)
|
2004-03-30 |
2013-02-11 |
Vertex Pharma |
Azaindoler, der kan anvendes som inhibitorer af JAK og andre proteinkinaser
|
FR2868422B1
(fr)
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
EP1740591B1
(en)
|
2004-04-02 |
2009-06-17 |
OSI Pharmaceuticals, Inc. |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
|
US20080275022A1
(en)
|
2004-06-15 |
2008-11-06 |
Astrazeneca Ab |
Substituted Quinazolones as Anti-Cancer Agents
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
WO2006020145A2
(en)
|
2004-07-19 |
2006-02-23 |
The Johns Hopkins University |
Flt3 inhibitors for immune suppression
|
MY144232A
(en)
|
2004-07-26 |
2011-08-15 |
Chugai Pharmaceutical Co Ltd |
5-substituted-2-phenylamino benzamides as mek inhibitors
|
WO2007040469A2
(en)
|
2005-09-15 |
2007-04-12 |
Kosak Ken M |
Chloroquine coupled compositions and methods for their synthesis
|
WO2006024834A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
BRPI0514679A
(pt)
|
2004-09-01 |
2008-06-17 |
Astrazeneca Ab |
composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, e, métodos para produzir um efeito inibitório de b-raf e um efeito anticáncer em um animal de sangue quente, e para tratar uma doença ou condição
|
PL1791830T3
(pl)
|
2004-09-17 |
2011-05-31 |
Vertex Pharma |
Związki diaminotriazolowe użyteczne jako inhibitory kinaz białkowych
|
EP1828147A1
(en)
|
2004-10-15 |
2007-09-05 |
AstraZeneca AB |
Quinoxalines as b-raf inhibitors
|
RU2007123675A
(ru)
|
2004-11-24 |
2008-12-27 |
Новартис АГ (CH) |
Комбинации ингибиторов jak
|
JP2008520615A
(ja)
|
2004-11-24 |
2008-06-19 |
ラボラトワール セローノ ソシエテ アノニム |
過増殖性障害を処置するためのmek阻害剤としての新規4−アリールアミノピリドン誘導体
|
AU2005311451A1
(en)
|
2004-12-01 |
2006-06-08 |
Merck Serono Sa |
[1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
|
JP2008521903A
(ja)
|
2004-12-01 |
2008-06-26 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
N置換されたベンズイミダゾリルC−kit阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
|
CN101128454A
(zh)
|
2004-12-22 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
用作抗癌药物的吡啶羧酰胺衍生物
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
BRPI0606930A2
(pt)
|
2005-01-25 |
2009-12-01 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, e, métodos para a produção de um efeito de inibição de b-raf em um animal de sangue quente, para a produção de um efeito anti-cáncer em um animal de sangue quente e para o tratamento de doenças de um animal em um animal de sangue quente
|
WO2006080450A1
(ja)
|
2005-01-27 |
2006-08-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Igf-1r阻害剤
|
EP2383268B1
(en)
|
2005-02-04 |
2015-09-02 |
AstraZeneca AB |
Pyrazolylaminopyridine derivatives useful as kinase inhibitors
|
BRPI0607455A2
(pt)
|
2005-02-16 |
2009-09-01 |
Astrazeneca Ab |
composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
|
BRPI0608160A2
(pt)
|
2005-02-16 |
2010-11-09 |
Astrazeneca Ab |
anticorpo isolado, célula hospedeira, método de inibir o crescimento de células psma+, e, uso de um anticorpo anti-psma defucosilado
|
KR100917511B1
(ko)
|
2005-02-28 |
2009-09-16 |
니뽄 다바코 산교 가부시키가이샤 |
Syk 저해 활성을 갖는 신규한 아미노피리딘 화합물
|
AU2006229343A1
(en)
|
2005-03-28 |
2006-10-05 |
Kirin Pharma Kabushiki Kaisha |
Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
|
AU2006231929B2
(en)
|
2005-04-04 |
2012-09-06 |
Ab Science |
Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
|
US7745641B2
(en)
|
2005-04-19 |
2010-06-29 |
Kyowa Hakko Kirin Co., Ltd. |
Nitrogen-containing heterocyclic compound
|
NZ564317A
(en)
|
2005-05-16 |
2011-01-28 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
PL2364973T3
(pl)
|
2005-05-18 |
2014-12-31 |
Array Biopharma Inc |
Heterocykliczne inhibitory MEK i sposoby ich stosowania
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
WO2006133417A1
(en)
|
2005-06-07 |
2006-12-14 |
Valeant Pharmaceuticals International |
Phenylamino isothiazole carboxamidines as mek inhibitors
|
US20070021435A1
(en)
|
2005-06-10 |
2007-01-25 |
Gaul Michael D |
Aminopyrimidines as kinase modulators
|
CA2611530C
(en)
|
2005-06-23 |
2012-11-20 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TW200738638A
(en)
|
2005-06-23 |
2007-10-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
TW200740820A
(en)
|
2005-07-05 |
2007-11-01 |
Takeda Pharmaceuticals Co |
Fused heterocyclic derivatives and use thereof
|
US20080207572A1
(en)
|
2005-07-14 |
2008-08-28 |
Ab Science |
Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple Myeloma
|
KR20080026654A
(ko)
|
2005-07-14 |
2008-03-25 |
아스텔라스세이야쿠 가부시키가이샤 |
헤테로시클릭 야누스 키나제 3 억제제
|
WO2007028445A1
(en)
|
2005-07-15 |
2007-03-15 |
Glaxo Group Limited |
6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
|
TW200740805A
(en)
|
2005-07-15 |
2007-11-01 |
Glaxo Group Ltd |
Novel compounds
|
EP1912636B1
(en)
|
2005-07-21 |
2014-06-25 |
Ardea Biosciences, Inc. |
N-(arylamino)-sulfonamide inhibitors of mek
|
JP4077028B2
(ja)
|
2005-08-24 |
2008-04-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
新規ピリジン誘導体およびピリミジン誘導体(3)
|
WO2007030680A2
(en)
|
2005-09-07 |
2007-03-15 |
Rigel Pharmaceuticals, Inc. |
Triazole derivatives useful as axl inhibitors
|
AU2006297089B2
(en)
|
2005-09-27 |
2012-05-03 |
Irm Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
|
FR2891273B1
(fr)
|
2005-09-27 |
2007-11-23 |
Aventis Pharma Sa |
NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
|
RS51782B
(en)
|
2005-10-07 |
2011-12-31 |
Exelixis Inc. |
AZETIDINS AS MAK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
|
WO2007042299A1
(en)
|
2005-10-13 |
2007-04-19 |
Glaxo Group Limited |
Pyrrolopyrimidine derivatives as syk inhibitors
|
US8217057B2
(en)
|
2005-12-05 |
2012-07-10 |
Pfizer Inc. |
Polymorphs of a c-MET/HGFR inhibitor
|
SI2348023T1
(sl)
|
2005-12-13 |
2015-10-30 |
Incyte Corporation |
S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b)pirimidini kot zaviralci janus kinaze
|
WO2007075554A2
(en)
|
2005-12-19 |
2007-07-05 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
JP2009520780A
(ja)
|
2005-12-21 |
2009-05-28 |
アストラゼネカ アクチボラグ |
癌の治療において有用なmek阻害剤である6−(4−ブロモ−2−クロロフェニルアミノ)−7−フルオロ−n−(2−ヒドロキシエトキシ)−3−メチル−3h−ベンゾイミダゾール−5−カルボキシアミドのトシル酸塩
|
AU2006328194A1
(en)
|
2005-12-22 |
2007-06-28 |
Astrazeneca Ab |
Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
|
TW201412738A
(zh)
|
2006-01-17 |
2014-04-01 |
Vertex Pharma |
適合作為傑納斯激酶(janus kinase)抑制劑之氮雜吲哚
|
FR2896503B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
WO2007085540A1
(en)
|
2006-01-27 |
2007-08-02 |
Glaxo Group Limited |
1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives
|
GB0601962D0
(en)
|
2006-01-31 |
2006-03-15 |
Ucb Sa |
Therapeutic agents
|
TW200740776A
(en)
|
2006-02-06 |
2007-11-01 |
Osi Pharm Inc |
N-phenylbenzotriazolyl c-kit inhibitors
|
ES2336625T3
(es)
|
2006-03-22 |
2010-04-14 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la proteina quinasa c-met para el tratamiento de trastornos proliferativos.
|
EP2001884A1
(en)
|
2006-04-05 |
2008-12-17 |
Vertex Pharmaceuticals, Inc. |
Deazapurines useful as inhibitors of janus kinases
|
EP2007737A2
(en)
|
2006-04-05 |
2008-12-31 |
AstraZeneca AB |
Chemical compounds
|
US20090163525A1
(en)
|
2006-04-05 |
2009-06-25 |
Astrazeneca Ab |
Substituted quinazolines with anti-cancer activity
|
US20090203718A1
(en)
|
2006-04-13 |
2009-08-13 |
Smithkline Beecham (Cork) Ltd. |
Cancer treatment method
|
EP2010504A1
(en)
|
2006-04-18 |
2009-01-07 |
AstraZeneca AB |
Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
|
JP5269762B2
(ja)
|
2006-04-18 |
2013-08-21 |
アーディア・バイオサイエンシーズ・インコーポレイテッド |
Mek阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド
|
EP2009005A4
(en)
|
2006-04-19 |
2010-06-02 |
Astellas Pharma Inc |
AZOLECARBOXAMIDE DERIVATIVE
|
JP5525812B2
(ja)
|
2006-04-19 |
2014-06-18 |
メルク セローノ ソシエテ アノニム |
Mekインヒビターとしての新規ヘテロアリール置換アリールアミノピリジン誘導体
|
CN102670605B
(zh)
|
2006-04-20 |
2015-07-29 |
詹森药业有限公司 |
抑制c kit激酶的方法
|
WO2007129226A2
(en)
|
2006-05-09 |
2007-11-15 |
New Era Biotech Ltd |
Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
|
US20090209580A1
(en)
|
2006-05-18 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
US20090281115A1
(en)
|
2006-06-30 |
2009-11-12 |
Board of Regents, The University of Texas System, a Texas University |
Inhibitors of c-kit and uses thereof
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
ATE456392T1
(de)
|
2006-07-20 |
2010-02-15 |
Amgen Inc |
Benzoädüisoxazol-derivate als c-kit-tyrosinkinase-hemmer zur behandlung von erkrankungen im zusammenhang mit der überproduktion von histamin
|
BRPI0714665A2
(pt)
|
2006-08-04 |
2012-03-13 |
Takeda Pharmaceutical Company Limited |
Composto, pró-droga, agente farmacêutico, e, método para a profilaxia ou tratamento do câncer
|
US20100216791A1
(en)
|
2006-08-17 |
2010-08-26 |
Astrazeneca |
Pyridinylquinazolinamine derivatives and their use as b-raf inhibitors
|
ES2375284T3
(es)
|
2006-08-23 |
2012-02-28 |
Eisai R&D Management Co., Ltd. |
Sal de un derivado de fenoxipiridina, o cristal de la misma, y procedimiento de producción de la misma.
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
PT2526933E
(pt)
|
2006-09-22 |
2015-06-23 |
Pharmacyclics Inc |
Inibidores da tirosina-quinase de bruton
|
WO2008045978A1
(en)
|
2006-10-10 |
2008-04-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors
|
KR20090064602A
(ko)
|
2006-10-16 |
2009-06-19 |
노파르티스 아게 |
단백질 키나제 억제제로서 유용한 페닐아세트아미드
|
WO2008047831A1
(fr)
|
2006-10-17 |
2008-04-24 |
Kyowa Hakko Kirin Co., Ltd. |
Inhibiteurs de JAK
|
TW200829566A
(en)
|
2006-12-08 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
PL2101759T3
(pl)
|
2006-12-14 |
2019-05-31 |
Exelixis Inc |
Sposoby stosowania inhibitorów MEK
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
US8895745B2
(en)
|
2006-12-22 |
2014-11-25 |
Astex Therapeutics Limited |
Bicyclic heterocyclic compounds as FGFR inhibitors
|
US7879856B2
(en)
|
2006-12-22 |
2011-02-01 |
Rigel Pharmaceuticals, Inc. |
Diaminothiazoles useful as Axl inhibitors
|
PL2078010T3
(pl)
|
2006-12-29 |
2014-07-31 |
Rigel Pharmaceuticals Inc |
Triazole podstawione policyklicznym heteroarylem użyteczne jako inhibitory Axl
|
ES2656496T3
(es)
|
2006-12-29 |
2018-02-27 |
Rigel Pharmaceuticals, Inc. |
Triazoles sustituidos útiles como inhibidores de AXL
|
EP2484679B1
(en)
|
2006-12-29 |
2016-09-28 |
Rigel Pharmaceuticals, Inc. |
N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
|
EP2114954B1
(en)
|
2006-12-29 |
2013-02-13 |
Rigel Pharmaceuticals, Inc. |
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
WO2008083357A1
(en)
|
2006-12-29 |
2008-07-10 |
Rigel Pharmaceuticals, Inc. |
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
|
EP1944369A1
(en)
|
2007-01-12 |
2008-07-16 |
The Centre National de la Recherche Scientifique |
Dbait and its standalone uses thereof
|
WO2008089459A1
(en)
|
2007-01-19 |
2008-07-24 |
Ardea Biosciences, Inc. |
Inhibitors of mek
|
WO2008098139A2
(en)
|
2007-02-07 |
2008-08-14 |
The Regents Of The University Of Colorado |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
US20120232049A1
(en)
|
2007-02-23 |
2012-09-13 |
Eisai R&D Management Co., Ltd. |
Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
|
KR20090115866A
(ko)
|
2007-03-05 |
2009-11-09 |
교와 핫꼬 기린 가부시키가이샤 |
의약 조성물
|
MX2009009792A
(es)
|
2007-03-12 |
2009-09-23 |
Cytopia Res Pty Ltd |
Compuestos de fenil amino pirimidina y usos de los mismos.
|
WO2008116139A2
(en)
|
2007-03-22 |
2008-09-25 |
Vertex Pharmaceuticals Incorporated |
N-heterocyclic compounds useful as inhibitors of janus kinases
|
EA017865B1
(ru)
|
2007-03-28 |
2013-03-29 |
Фармасайкликс, Инк. |
Ингибиторы тирозинкиназы брутона
|
US7998966B2
(en)
|
2007-04-13 |
2011-08-16 |
Supergen, Inc. |
Axl kinase inhibitors
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
GB0714384D0
(en)
|
2007-07-23 |
2007-09-05 |
Ucb Pharma Sa |
theraputic agents
|
UA99731C2
(ru)
|
2007-07-30 |
2012-09-25 |
Ардеа Биосайенсис, Инк |
Кристаллические полиморфные формы n-(ариламино)сульфонамидов как ингибиторы мэк, композиция (варианты) и применение
|
KR20100092424A
(ko)
|
2007-07-30 |
2010-08-20 |
아디아 바이오사이언스즈 인크. |
다형체를 포함하는, mek의 억제제로서의 n-(아릴아미노) 술폰아미드의 유도체 및 조성물, 사용 방법 및 이의 제조 방법
|
PA8792501A1
(es)
|
2007-08-09 |
2009-04-23 |
Sanofi Aventis |
Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
|
NZ583582A
(en)
|
2007-09-05 |
2012-02-24 |
Rigel Pharmaceuticals Inc |
Xinafoate salt of n4-(2, 2-difluoro-4h-benzo [1,4] oxazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocarbonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
|
ES2444144T3
(es)
|
2007-10-23 |
2014-02-24 |
F. Hoffmann-La Roche Ag |
Nuevos inhibidores de quinasa
|
ES2498065T3
(es)
|
2007-10-24 |
2014-09-24 |
Astellas Pharma Inc. |
Compuesto de azolcarboxamida o sal del mismo
|
EP2205592B1
(en)
|
2007-10-26 |
2013-05-08 |
Rigel Pharmaceuticals, Inc. |
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
|
WO2009062258A1
(en)
|
2007-11-15 |
2009-05-22 |
Cytopia Research Pty Ltd |
N-containing heterocyclic compounds
|
US20110039856A1
(en)
|
2007-11-29 |
2011-02-17 |
Pfizer Inc. |
Polymorphs of a c-met/hgfr inhibitor
|
EP2240494B1
(en)
|
2008-01-21 |
2016-03-30 |
UCB Biopharma SPRL |
Thieno-pyridine derivatives as mek inhibitors
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
WO2009095399A2
(en)
|
2008-02-01 |
2009-08-06 |
Akinion Pharmaceuticals Ab |
Pyrazine derivatives and their use as protein kinase inhbitors
|
RU2505538C2
(ru)
|
2008-02-05 |
2014-01-27 |
Ф.Хоффманн-Ля Рош Аг |
Новые пиридиноны и пиридазиноны
|
KR101216323B1
(ko)
|
2008-02-22 |
2012-12-27 |
아이알엠 엘엘씨 |
C?kit 및 pdgfr 키나제 억제제로서의 헤테로시클릭 화합물 및 조성물
|
WO2009111280A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
KR20100122505A
(ko)
|
2008-02-29 |
2010-11-22 |
어레이 바이오파마 인크. |
Raf 저해물질 화합물 및 이들의 이용 방법
|
EP2265609B1
(en)
|
2008-02-29 |
2012-09-05 |
Array Biopharma, Inc. |
Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
|
AR072657A1
(es)
|
2008-02-29 |
2010-09-15 |
Genentech Inc |
Compuestos inhibidores de raf y metodos para su uso
|
BRPI0909040B8
(pt)
|
2008-03-11 |
2021-05-25 |
Incyte Holdings Corp |
derivados de azetidina e ciclobutano, seus usos, e composição
|
WO2009117097A1
(en)
|
2008-03-19 |
2009-09-24 |
Chembridge Corporation |
Novel tyrosine kinase inhibitors
|
EP3604533A1
(en)
|
2008-04-11 |
2020-02-05 |
Arbutus Biopharma Corporation |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
EA201001639A1
(ru)
|
2008-04-14 |
2011-06-30 |
Арди Байосайенсиз, Инк. |
Композиции и способы их получения и применения
|
MX2010011224A
(es)
|
2008-04-16 |
2011-02-25 |
Max Planck Ges Zur Fa Rderung Der Wissenschaften E V |
Derivados de quinoleina como inhibidores de la cinasa axl.
|
CA2723205C
(en)
|
2008-04-16 |
2017-03-14 |
Portola Pharmaceuticals, Inc. |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinase inhibitors
|
KR101773313B1
(ko)
|
2008-04-16 |
2017-08-31 |
포톨라 파마슈티컬스, 인코포레이티드 |
syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드
|
CA2723185A1
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
US8871753B2
(en)
|
2008-04-24 |
2014-10-28 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
KR101781605B1
(ko)
|
2008-05-21 |
2017-09-25 |
어리어드 파마슈티칼스, 인코포레이티드 |
키나아제 억제제로서 포스포러스 유도체
|
CA2724742C
(en)
|
2008-05-21 |
2016-07-19 |
Incyte Corporation |
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
|
GB0811304D0
(en)
|
2008-06-19 |
2008-07-30 |
Ucb Pharma Sa |
Therapeutic agents
|
PE20110062A1
(es)
|
2008-06-19 |
2011-03-09 |
Astrazeneca Ab |
N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
|
KR20110031475A
(ko)
|
2008-06-20 |
2011-03-28 |
제넨테크, 인크. |
트리아졸로피리딘 jak 억제제 화합물 및 방법
|
MX2010014005A
(es)
|
2008-06-20 |
2011-02-15 |
Genentech Inc |
Compuestos de triazolopiridina inhibidores de jak y los metodos.
|
JP5536049B2
(ja)
|
2008-06-24 |
2014-07-02 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規な置換ピリジン−2−オン及びピリダジン−3−オン
|
EP2326641B1
(en)
|
2008-07-09 |
2014-09-03 |
Rigel Pharmaceuticals, Inc. |
Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
|
JP5613156B2
(ja)
|
2008-07-09 |
2014-10-22 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Axl阻害剤として有用な架橋二環ヘテロアリール置換トリアゾール
|
CN102159214A
(zh)
|
2008-07-16 |
2011-08-17 |
药品循环公司 |
用于实体肿瘤的治疗的布鲁顿酪氨酸激酶的抑制剂
|
FR2933982A1
(fr)
|
2008-07-18 |
2010-01-22 |
Sanofi Aventis |
Nouveaux derives imidazo°1,2-a!pyrimidine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
|
AR072518A1
(es)
|
2008-07-18 |
2010-09-01 |
Sanofi Aventis |
Derivados de imidazo [1,2-a]piridina, su procedimiento de preparacion, composiciones farmaceuticas y su utilizacion particularmente como inhibidores de met."
|
US20110263594A1
(en)
|
2008-07-18 |
2011-10-27 |
Sanofi-Aventis |
Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
|
PE20110665A1
(es)
|
2008-08-04 |
2011-09-23 |
Merck Patent Gmbh |
Compuestos derivados de n-cichohexil-3-(fenilamino)-isonicotinamida como inhibidores de mek
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
SG196855A1
(en)
|
2008-10-22 |
2014-02-13 |
Array Biopharma Inc |
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
|
AU2009308675A1
(en)
|
2008-10-31 |
2010-05-06 |
Genentech, Inc. |
Pyrazolopyrimidine JAK inhibitor compounds and methods
|
EP2365970B1
(en)
|
2008-11-12 |
2018-03-21 |
Gilead Connecticut, Inc. |
Pyridazinones and their use as btk inhibitors
|
JP5596047B2
(ja)
|
2008-11-19 |
2014-09-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
c−Metタンパク質キナーゼのトリアゾロチアジアゾール阻害剤
|
EP3123864A1
(en)
|
2008-12-08 |
2017-02-01 |
Gilead Connecticut, Inc. |
Imidazopyrazine syk inhibitors
|
US8440667B2
(en)
|
2008-12-08 |
2013-05-14 |
Gilead Connecticut, Inc. |
Imidazopyrazine Syk inhibitors
|
ITMI20082336A1
(it)
|
2008-12-29 |
2010-06-30 |
Univ Parma |
Composti inibitori irreversibili di egfr con attivita' antiproliferativa
|
MX2011007499A
(es)
|
2009-01-13 |
2011-08-04 |
Glaxo Group Ltd |
Derivados de pirimidin-carboxamida como inhibidores de la cinasa syk.
|
JOP20190230A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
RU2555326C2
(ru)
|
2009-01-16 |
2015-07-10 |
Риджел Фармасьютикалз, Инк. |
ИНГИБИТОРЫ Axl ДЛЯ ПРИМЕНЕНИЯ В КОМБИНИРОВАННОЙ ТЕРАПИИ ДЛЯ ПРЕДОТВРАЩЕНИЯ, УСТРАНЕНИЯ ИЛИ ЛЕЧЕНИЯ МЕТАСТAЗИРУЮЩЕГО РАКА
|
WO2010085597A1
(en)
|
2009-01-23 |
2010-07-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
FR2941952B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
FR2941951B1
(fr)
|
2009-02-06 |
2011-04-01 |
Sanofi Aventis |
Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
|
SG172857A1
(en)
|
2009-02-09 |
2011-08-29 |
Supergen Inc |
Pyrrolopyrimidinyl axl kinase inhibitors
|
WO2010108652A1
(en)
|
2009-03-27 |
2010-09-30 |
Ardea Biosciences Inc. |
Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
|
AU2009344690A1
(en)
|
2009-04-21 |
2011-10-27 |
Novartis Ag |
Heterocyclic compounds as MEK inhibitors
|
EP2424368B1
(en)
|
2009-04-29 |
2014-12-31 |
Locus Pharmaceuticals, Inc. |
Pyrrolotriazine compounds
|
WO2010129053A2
(en)
|
2009-05-05 |
2010-11-11 |
Dana Farber Cancer Institute |
Egfr inhibitors and methods of treating disorders
|
HUE046493T2
(hu)
|
2009-05-22 |
2020-03-30 |
Incyte Holdings Corp |
3-[4-(7H-Pirrolo[2,3-d]pirimidin-4-il)-lH-pirazol-l-il]oktán- vagy heptán-nitril JAK inhibitorokként
|
CN102459172B
(zh)
|
2009-06-10 |
2015-06-24 |
中外制药株式会社 |
四环化合物
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
CN102134218A
(zh)
|
2009-06-15 |
2011-07-27 |
凯美隆(北京)药业技术有限公司 |
6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂
|
WO2010147898A2
(en)
|
2009-06-15 |
2010-12-23 |
Rigel Pharmaceuticals, Inc. |
Small molecule inhibitors of spleen tyrosine kinase (syk)
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
US8722692B2
(en)
|
2009-07-30 |
2014-05-13 |
Jianwei Che |
Compounds and compositions as Syk kinase inhibitors
|
TW201105669A
(en)
|
2009-07-30 |
2011-02-16 |
Irm Llc |
Compounds and compositions as Syk kinase inhibitors
|
EP2470511A1
(en)
|
2009-08-28 |
2012-07-04 |
Genentech, Inc. |
Raf inhibitor compounds and methods of use thereof
|
CN102858754A
(zh)
|
2009-08-28 |
2013-01-02 |
阵列生物制药公司 |
Raf抑制剂化合物及其使用方法
|
CA2771895A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
CA2772316A1
(en)
|
2009-08-28 |
2011-03-03 |
Array Biopharma Inc. |
1h-pyrazolo [3,4-b] pyridine compounds for inhibiting raf kinase
|
EP2485589A4
(en)
|
2009-09-04 |
2013-02-06 |
Biogen Idec Inc |
HETEROARYARY INHIBITORS OF BTK
|
US8785440B2
(en)
|
2009-09-04 |
2014-07-22 |
Biogen Idec Ma, Inc. |
Bruton's tyrosine kinase inhibitors
|
US9238571B2
(en)
|
2009-09-30 |
2016-01-19 |
Merck Sharp & Dohme Limited |
Formulations for c-Met kinase inhibitors
|
US9034861B2
(en)
|
2009-10-13 |
2015-05-19 |
Allomek Therapeutics Llc |
MEK inhibitors useful in the treatment of diseases
|
PT4159217T
(pt)
|
2009-10-16 |
2024-08-12 |
Novartis Ag |
Combinação que compreende um inibidor de mek e um inibidor de b-raf
|
ES2487628T3
(es)
|
2009-11-04 |
2014-08-22 |
Novartis Ag |
Derivados de sulfonamida heterocíclica útiles como inhibidores de MEK
|
US8735417B2
(en)
|
2009-12-17 |
2014-05-27 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as Syk inhibitors
|
SG181803A1
(en)
|
2009-12-17 |
2012-07-30 |
Merck Sharp & Dohme |
Aminopyrimidines as syk inhibitors
|
EP2516434B1
(en)
|
2009-12-23 |
2015-05-27 |
Takeda Pharmaceutical Company Limited |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
RU2556205C2
(ru)
|
2009-12-23 |
2015-07-10 |
Аркьюл, Инк. |
Очищенные пирролохинолинил-пирролидин-2,5-дионовые композиции и способы их получения и применения
|
EP2338888A1
(en)
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridine derivatives as JAK inhibitors
|
EP2937345B1
(en)
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
SG182480A1
(en)
|
2010-01-12 |
2012-08-30 |
Ab Science |
Thiazole and oxazole kinase inhibitors
|
WO2011092128A1
(en)
|
2010-01-29 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Substituted naphthyridines and their use as syk kinase inhibitors
|
AU2011226689B2
(en)
|
2010-03-11 |
2016-09-01 |
Kronos Bio, Inc. |
Imidazopyridines Syk inhibitors
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
RU2640862C2
(ru)
|
2010-03-24 |
2018-01-18 |
Амитек Терапетикс Солюшинс, Инк. |
Гетероциклические соединения, эффективные для ингибирования киназы
|
WO2011121223A1
(fr)
|
2010-03-30 |
2011-10-06 |
Sanofi-Aventis |
Derives de 6-(alkyl- ou cycloalkyl-triazolopyridazine-sulfanyl) benzothiazoles: preparation, application comme medicaments et utilisation comme inhibiteurs de met
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
WO2011138751A2
(en)
|
2010-05-04 |
2011-11-10 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
JP2013526570A
(ja)
|
2010-05-14 |
2013-06-24 |
オーエスアイ・ファーマシューティカルズ,エルエルシー |
縮合二環式キナーゼ阻害剤
|
CA2799904A1
(en)
|
2010-05-20 |
2011-11-24 |
F. Hoffmann-La Roche Ag |
Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
|
JP2013526558A
(ja)
|
2010-05-20 |
2013-06-24 |
エフ.ホフマン−ラ ロシュ アーゲー |
Syk及びjak阻害剤としてのピロロピラジン誘導体
|
US8263777B2
(en)
|
2010-05-27 |
2012-09-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase
|
EP2576566B1
(en)
|
2010-05-28 |
2015-10-28 |
Merck Sharp & Dohme B.V. |
Thieno(2,3b)pyrazine compounds as b-raf inhibitors
|
HUE030720T2
(en)
|
2010-05-31 |
2017-06-28 |
Ono Pharmaceutical Co |
Purinone derivative as btk kinase inhibitor
|
CN107898791A
(zh)
|
2010-06-03 |
2018-04-13 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶(btk)抑制剂的应用
|
US9205099B2
(en)
|
2010-06-22 |
2015-12-08 |
Dna Therapeutics |
Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
|
AU2011272198B2
(en)
|
2010-06-30 |
2016-09-22 |
Fujifilm Corporation |
Novel nicotinamide derivatives or salts thereof
|
JPWO2012005299A1
(ja)
|
2010-07-07 |
2013-09-05 |
日本新薬株式会社 |
Rosチロシンキナーゼ阻害剤
|
WO2012006960A1
(en)
|
2010-07-14 |
2012-01-19 |
Zhejiang Beta Pharma Inc. |
NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
CN103003262A
(zh)
|
2010-07-16 |
2013-03-27 |
协和发酵麒麟株式会社 |
含氮芳香族杂环衍生物
|
AR085183A1
(es)
|
2010-07-30 |
2013-09-18 |
Lilly Co Eli |
Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
BR112013003388A2
(pt)
|
2010-08-10 |
2016-07-12 |
Celgene Avilomics Res Inc |
sal de besilato de um inibidor de btk
|
BR112013003879B1
(pt)
|
2010-08-20 |
2020-12-22 |
Chugai Seiyaku Kabushiki Kaisha |
composição compreendendo compostos tetracíclicos e formulação oralmente administrável que a compreende
|
JP5789300B2
(ja)
|
2010-08-27 |
2015-10-07 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
フロピリジン誘導体
|
KR20130110163A
(ko)
|
2010-08-27 |
2013-10-08 |
메르크 파텐트 게엠베하 |
트리아졸로피라진 유도체들
|
EP2423208A1
(en)
|
2010-08-28 |
2012-02-29 |
Lead Discovery Center GmbH |
Pharmaceutically active compounds as Axl inhibitors
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
US8664244B2
(en)
|
2010-09-12 |
2014-03-04 |
Advenchen Pharmaceuticals, LLC |
Compounds as c-Met kinase inhibitors
|
WO2012037155A2
(en)
|
2010-09-13 |
2012-03-22 |
Gtx, Inc. |
Tyrosine kinase inhibitors
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
KR20130139987A
(ko)
|
2010-10-08 |
2013-12-23 |
엑스커버리 홀딩 컴퍼니 엘엘씨 |
키나아제 억제제 화합물로서 치환된 피리다진 카복사미드 화합물
|
AU2011323484B2
(en)
|
2010-11-01 |
2016-10-06 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as Syk modulators
|
CN102020651B
(zh)
|
2010-11-02 |
2012-07-18 |
北京赛林泰医药技术有限公司 |
6-芳基氨基吡啶酮甲酰胺mek抑制剂
|
CN102532141A
(zh)
|
2010-12-08 |
2012-07-04 |
中国科学院上海药物研究所 |
[1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
MA34969B1
(fr)
|
2011-02-25 |
2014-03-01 |
Irm Llc |
Composes et compositions en tant qu inibiteurs de trk
|
WO2012123312A1
(en)
|
2011-03-11 |
2012-09-20 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
MX342310B
(es)
|
2011-03-28 |
2016-09-26 |
Hoffmann La Roche |
Compuestos de tiazolopirimidina.
|
ES2759615T3
(es)
|
2011-04-01 |
2020-05-11 |
Univ Utah Res Found |
Análogos de N-fenilpirimidina-2-amina sustituidos como inhibidores de la quinasa AXL
|
US8703767B2
(en)
|
2011-04-01 |
2014-04-22 |
University Of Utah Research Foundation |
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
|
PE20141050A1
(es)
|
2011-04-05 |
2014-08-30 |
Pfizer Ltd |
Inhibidores de quinasa relacionados con pirrolo (2,3-d) pirimidina tropomiosina
|
WO2012151137A1
(en)
|
2011-05-04 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
|
AU2012253886A1
(en)
|
2011-05-10 |
2013-10-31 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as Syk inhibitors
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
CA2834604A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
RS55582B1
(sr)
|
2011-05-13 |
2017-06-30 |
Array Biopharma Inc |
Jedinjenja pirolidinil uree, pirolidinil tiouree i pirolidinil guanidina kao inhibitori trka kinaze
|
EP2527440A1
(en)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
WO2012167423A1
(en)
|
2011-06-08 |
2012-12-13 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as novel syk inhibitors
|
CN102816162B
(zh)
|
2011-06-10 |
2016-04-27 |
中国科学院广州生物医药与健康研究院 |
嘧啶并嘧啶酮类化合物及其药用组合物和应用
|
DK2718270T3
(da)
|
2011-06-10 |
2022-08-01 |
Merck Patent Gmbh |
Sammensætninger og fremgangsmåder til fremstillingen af pyrimidin- og pyridinforbindelser med btk-hæmmende aktivitet
|
CN102393896B
(zh)
|
2011-07-11 |
2014-08-27 |
成都西谷曙光数字技术有限公司 |
一种简单精确的射频定位系统和方法
|
WO2013009582A1
(en)
|
2011-07-12 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
EA034558B1
(ru)
|
2011-07-19 |
2020-02-20 |
Мерк Шарп и Доум Б.В. |
4-ИМИДАЗО[1,5-a]ПИРИДАЗИН-1-ИЛ-БЕНЗАМИДЫ В КАЧЕСТВЕ Btk-ИНГИБИТОРОВ
|
AU2012285988B2
(en)
|
2011-07-19 |
2017-05-25 |
Merck Sharp & Dohme B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides Btk-inhibitors
|
CA2842841C
(en)
|
2011-07-27 |
2016-04-19 |
Nanjing Allgen Pharma Co. Ltd. |
Spirocyclic molecules as protein kinase inhibitors
|
CA2840029C
(en)
|
2011-07-27 |
2021-07-20 |
Ab Science |
Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
|
US20150011508A1
(en)
|
2011-09-01 |
2015-01-08 |
Irm Llc |
Compounds and compositions as c-kit kinase inhibitors
|
BR112014003963A2
(pt)
|
2011-09-01 |
2017-03-21 |
Irm Llc |
compostos e composições como inibidores de quinase c-kit
|
KR101962495B1
(ko)
|
2011-09-01 |
2019-03-26 |
노파르티스 아게 |
C-kit 키나제 억제제로서의 화합물 및 조성물
|
US9199981B2
(en)
|
2011-09-01 |
2015-12-01 |
Novartis Ag |
Compounds and compositions as C-kit kinase inhibitors
|
EP2755657B1
(en)
|
2011-09-14 |
2017-11-29 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
JP5878178B2
(ja)
|
2011-09-30 |
2016-03-08 |
大鵬薬品工業株式会社 |
1,2,4−トリアジン−6−カルボキサミド誘導体
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
US9006444B2
(en)
|
2011-10-05 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
WO2013052394A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
MX361772B
(es)
|
2011-10-19 |
2018-12-17 |
Pharmacyclics Llc |
Uso de inhibidores de la tirosina cinasa de bruton (btk).
|
RU2662443C2
(ru)
|
2011-11-01 |
2018-07-26 |
Ф. Хоффманн-Ля Рош Аг |
Имидазопиридазины
|
BR112014010460A2
(pt)
|
2011-11-03 |
2017-04-18 |
Hoffmann La Roche |
composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica
|
PE20141686A1
(es)
|
2011-11-03 |
2014-11-08 |
Hoffmann La Roche |
Compuestos de piperazina alquilados como inhibidores de actividad btk
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
EA023521B1
(ru)
|
2011-11-14 |
2016-06-30 |
Сефалон, Инк. |
ПРОИЗВОДНЫЕ УРАЦИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ AXL И c-MET КИНАЗЫ
|
RU2615999C2
(ru)
|
2011-11-29 |
2017-04-12 |
Оно Фармасьютикал Ко., Лтд. |
Гидрохлорид производного пуринона
|
EP2791138B1
(en)
|
2011-12-12 |
2018-06-06 |
Dr. Reddy's Laboratories Ltd. |
Substituted pyrazolo[1,5-a]pyridine as tropomyosin receptor kinase (trk) inhibitors
|
LT2796460T
(lt)
|
2011-12-21 |
2018-10-10 |
Jiangsu Hengrui Medicine Co. Ltd. |
Pirolo šešianario heteroarilo žiedo darinys, jo gavimo būdas ir jo medicininis panaudojimas
|
ES2661444T3
(es)
|
2011-12-28 |
2018-04-02 |
Fujifilm Corporation |
Nuevo derivado de nicotinamida o sal del mismo
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
EP2802590B1
(en)
|
2012-01-10 |
2017-03-01 |
F. Hoffmann-La Roche AG |
Thienopyrimidine compounds
|
CA2860547A1
(en)
|
2012-01-10 |
2013-07-18 |
Johannes Cornelius Hermann |
Pyridazine amide compounds and their use as syk inhibitors
|
CN103204825B
(zh)
|
2012-01-17 |
2015-03-04 |
上海科州药物研发有限公司 |
作为蛋白激酶抑制剂的苯并噻唑化合物及其制备方法和用途
|
CN103204844A
(zh)
|
2012-01-17 |
2013-07-17 |
上海艾力斯医药科技有限公司 |
氨基杂芳基化合物及其制备方法与应用
|
US9108973B2
(en)
|
2012-01-19 |
2015-08-18 |
Taiho Pharmaceutical Co., Ltd. |
3,5-disubstituted alkynylbenzene compound and salt thereof
|
JP6062962B2
(ja)
|
2012-01-20 |
2017-01-18 |
ジェノスコ |
置換ピリミジン化合物およびsyk阻害剤としてのそれらの使用
|
RS55728B1
(sr)
|
2012-01-31 |
2017-07-31 |
Daiichi Sankyo Co Ltd |
Derivat piridona
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
WO2013124869A2
(en)
|
2012-02-21 |
2013-08-29 |
Amrita Vishwa Vidyapeetham University |
The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
|
EP2817306B1
(en)
|
2012-02-21 |
2015-09-16 |
Merck Patent GmbH |
Cyclic diaminopyrimidine derivatives as syk inhibitors
|
CN104114558B
(zh)
|
2012-02-21 |
2016-10-26 |
默克专利股份公司 |
呋喃并吡啶衍生物
|
AU2013224421B2
(en)
|
2012-02-21 |
2017-03-02 |
Merck Patent Gmbh |
8 - substituted 2 -amino - [1,2,4] triazolo [1, 5 -a] pyrazines as Syk tryrosine kinase inhibitors and GCN2 serin kinase inhibitors
|
PT2821402T
(pt)
|
2012-02-28 |
2019-10-02 |
Kotobuki Pharmaceutical Co Ltd |
Composto aromático heterocíclico que contém nitrogénio
|
MX355526B
(es)
|
2012-03-14 |
2018-04-20 |
Lupin Ltd |
Compuesto de heterociclilo.
|
US9056839B2
(en)
|
2012-03-15 |
2015-06-16 |
Celgene Avilomics Research, Inc. |
Solid forms of an epidermal growth factor receptor kinase inhibitor
|
PL2828259T3
(pl)
|
2012-03-22 |
2019-02-28 |
Oscotec, Inc. |
Podstawione związki pirydopirymidynowe oraz ich zastosowanie jako inhibitory flt3
|
WO2013148603A1
(en)
|
2012-03-27 |
2013-10-03 |
Takeda Pharmaceutical Company Limited |
Cinnoline derivatives as as btk inhibitors
|
CA2866229C
(en)
|
2012-03-30 |
2020-09-15 |
Novartis Ag |
Fgfr inhibitor for use in the treatment of hypophosphatemic disorders
|
EP2834246B1
(en)
|
2012-04-03 |
2021-07-28 |
Novartis AG |
Combination products with tyrosine kinase inhibitors and their use
|
EP2833886B1
(en)
|
2012-04-04 |
2020-08-12 |
HangzhouDeRenYuCheng Biotechnology Ltd. |
Substituted quinolines as bruton's tyrosine kinase inhibitors
|
ES2657955T3
(es)
|
2012-04-17 |
2018-03-07 |
Fujifilm Corporation |
Compuesto heterocíclico que contiene nitrógeno o sal del mismo
|
EP3336181B1
(en)
|
2012-04-18 |
2022-01-12 |
Cell Signaling Technology, Inc. |
Egfr and ros1 in cancer
|
EP2842955B1
(en)
|
2012-04-26 |
2016-10-05 |
ONO Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
JP6114820B2
(ja)
|
2012-05-14 |
2017-04-12 |
イースト チャイナ ユニバーシティ オブ サイエンス アンド テクノロジー |
プテリジノン誘導体およびegfr、blk、flt3の阻害剤としての応用
|
WO2013176970A1
(en)
|
2012-05-22 |
2013-11-28 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
CN104470918A
(zh)
|
2012-05-30 |
2015-03-25 |
日本新药株式会社 |
芳香族杂环衍生物及医药
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并[1,2-b]嗒衍生物
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
RS55908B1
(sr)
|
2012-06-13 |
2017-09-29 |
Incyte Holdings Corp |
Substituisana triciklična jedinjenja kao inhibitori fgfr
|
CA2871659C
(en)
|
2012-06-14 |
2017-04-04 |
Eli Lilly And Company |
Inhibitor of jak1 and jak2
|
WO2013192125A1
(en)
|
2012-06-20 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
EP2863913B1
(en)
|
2012-06-20 |
2018-09-12 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
US9376418B2
(en)
|
2012-06-22 |
2016-06-28 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
|
WO2013192088A1
(en)
|
2012-06-22 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
TWI520962B
(zh)
|
2012-06-29 |
2016-02-11 |
|
As the c-Met tyrosine kinase inhibitors novel fused pyridine derivatives
|
CA2782774A1
(en)
|
2012-07-06 |
2014-01-06 |
Pharmascience Inc. |
Protein kinase inhibitors
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
CA2881279C
(en)
|
2012-08-07 |
2020-07-07 |
Merck Patent Gmbh |
Pyridopyrimidine derivatives as protein kinase inhibitors
|
WO2014026125A1
(en)
|
2012-08-10 |
2014-02-13 |
Incyte Corporation |
Pyrazine derivatives as fgfr inhibitors
|
WO2014025976A1
(en)
|
2012-08-10 |
2014-02-13 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors
|
BR112015003058A2
(pt)
|
2012-08-13 |
2017-07-04 |
Novartis Ag |
derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)
|
EP2884982B1
(en)
|
2012-08-20 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
WO2014029732A1
(en)
|
2012-08-21 |
2014-02-27 |
F. Hoffmann-La Roche Ag |
Pyrrolo[2,3-b]pyrazines as syk inhibitors
|
CN103122000B
(zh)
|
2012-09-03 |
2013-12-25 |
中美冠科生物技术(太仓)有限公司 |
用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
|
HUE044146T2
(hu)
|
2012-09-10 |
2019-09-30 |
Principia Biopharma Inc |
Pirazolopirimidin vegyületek mint kináz inhibitorok
|
WO2014045029A1
(en)
|
2012-09-18 |
2014-03-27 |
Ziarco Pharma Ltd |
2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
|
CN104640548A
(zh)
|
2012-09-25 |
2015-05-20 |
中外制药株式会社 |
Ret抑制剂
|
US9469654B2
(en)
|
2012-09-27 |
2016-10-18 |
Portola Pharmaceuticals, Inc. |
Bicyclic oxa-lactam kinase inhibitors
|
US9586931B2
(en)
|
2012-09-28 |
2017-03-07 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as Syk inhibitors
|
EP2903971B1
(en)
|
2012-10-04 |
2019-06-12 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
JP6401169B2
(ja)
|
2012-10-04 |
2018-10-03 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
チロシン受容体キナーゼbtk阻害剤としての置換n−(3−(ピリミジン−4−イル)フェニル)アクリルアミド類似体
|
US10112928B2
(en)
|
2012-10-19 |
2018-10-30 |
Hoffmann-La Roche Inc. |
Inhibitors of SYK
|
CA2880326A1
(en)
|
2012-10-26 |
2014-05-01 |
F. Hoffmann-La Roche Ag |
3,4-disubstituted 1 h-pyrazole and 4,5-disubstituted thiazole inhibitors of syk cap
|
US20150291554A1
(en)
|
2012-11-02 |
2015-10-15 |
Pfizer Inc. |
Bruton's Tyrosine Kinase Inhibitors
|
CN102977014B
(zh)
|
2012-11-05 |
2015-01-07 |
沈阳药科大学 |
新的喹啉类化合物及其用途
|
EP2916836A4
(en)
|
2012-11-07 |
2016-08-03 |
Merck Sharp & Dohme |
AMINOPYRIDE-CONTAINING MILK TYROSINE KINASE (SYK) INHIBITOR
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
WO2014078372A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
AU2013344943B2
(en)
|
2012-11-13 |
2017-06-29 |
Array Biopharma Inc. |
N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9790210B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
EA201590855A1
(ru)
|
2012-11-15 |
2015-11-30 |
Фармасайкликс, Инк. |
Соединения пирролопиримидина как ингибиторы киназ
|
CN103848810A
(zh)
|
2012-11-30 |
2014-06-11 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
WO2014086032A1
(en)
|
2012-12-07 |
2014-06-12 |
Hutchison Medipharma Limited |
Substituted pyridopyrazines as syk inhibitors
|
US9624210B2
(en)
|
2012-12-12 |
2017-04-18 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors
|
WO2014100314A1
(en)
|
2012-12-21 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
WO2014105958A2
(en)
|
2012-12-26 |
2014-07-03 |
Medivation Technologies, Inc. |
Fused pyrimidine compounds and use thereof
|
DK2940014T3
(en)
|
2012-12-28 |
2018-12-10 |
Crystalgenomics Inc |
2,3-DIHYDRO-ISOINDOL-1-ON DERIVATIVE AS BTK KINase INHIBITORS AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
|
DK2947084T3
(da)
|
2013-01-18 |
2020-11-02 |
Guangzhou Maxinovel Pharmaceuticals Co |
Fem- og seks-ledet heterocyklisk forbindelse og forberedelsesmetode, farmaceutisk sammensætning og anvendelse deraf
|
US9481682B2
(en)
|
2013-01-23 |
2016-11-01 |
Merck Sharp & Dohme Corp. |
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014113932A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014123167A1
(ja)
|
2013-02-08 |
2014-08-14 |
日産化学工業株式会社 |
3環性ピロロピリジン化合物及びjak阻害剤
|
HUE042591T2
(hu)
|
2013-02-19 |
2019-07-29 |
Ono Pharmaceutical Co |
TRK-gátló vegyület
|
AR094812A1
(es)
|
2013-02-20 |
2015-08-26 |
Eisai R&D Man Co Ltd |
Derivado de piridina monocíclico como inhibidor del fgfr
|
WO2014130693A1
(en)
|
2013-02-25 |
2014-08-28 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
JO3377B1
(ar)
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
AU2014249158B2
(en)
|
2013-03-11 |
2016-07-28 |
Ignyta, Inc. |
Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor
|
WO2014141129A2
(en)
|
2013-03-14 |
2014-09-18 |
Grueneberg Dorre A |
Novel methods, compounds, and compositions for inhibition of ros
|
EP2970163B1
(en)
|
2013-03-14 |
2018-02-28 |
Boehringer Ingelheim International GmbH |
5-thiazolecarboxamide dervatives and their use as btk inhibitors
|
EP2970300B1
(en)
|
2013-03-15 |
2018-05-16 |
Boehringer Ingelheim International GmbH |
Heteroaromatic compounds as btk inhibitors
|
KR20150130311A
(ko)
|
2013-03-19 |
2015-11-23 |
머크 샤프 앤드 돔 코포레이션 |
야누스 키나제 억제제로서의 n-(2-시아노 헤테로시클릴)피라졸로 피리돈
|
US9617260B2
(en)
|
2013-04-02 |
2017-04-11 |
Hoffmann-La Roche Inc. |
Inhibitors of bruton's tyrosine kinase
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
US10072298B2
(en)
*
|
2013-04-17 |
2018-09-11 |
Life Technologies Corporation |
Gene fusions and gene variants associated with cancer
|
MX367878B
(es)
|
2013-04-19 |
2019-09-10 |
Incyte Holdings Corp |
Heterociclos bicíclicos como inhibidores de los receptores del factor de crecimiento de fibroblastos (fgfr).
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
WO2014176210A1
(en)
|
2013-04-26 |
2014-10-30 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
JP6355719B2
(ja)
|
2013-05-10 |
2018-07-11 |
ジエンス ハンセン ファーマセウティカル カンパニー リミテッド |
[1,2,4]トリアゾール[4,3−a]ピリジン誘導体、その製造方法またはその医薬応用
|
EP4275756A3
(en)
|
2013-05-17 |
2024-02-07 |
Incyte Holdings Corporation |
Bipyrazole derivatives as jak inhibitors
|
JP6139782B2
(ja)
|
2013-05-21 |
2017-05-31 |
チャンスー メドリューション リミテッド |
置換ピラゾロピリミジン化合物、及びその薬学的に許容される塩、並びにこれらの溶媒和物、立体異性体、及び互変異性体、並びにこれらを含む医薬組成物
|
CA2912806A1
(en)
|
2013-05-29 |
2014-12-04 |
Cephalon, Inc. |
Pyrrolotriazines as alk inhibitors
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
TW201534597A
(zh)
|
2013-06-20 |
2015-09-16 |
Ab Science |
作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物
|
UY35630A
(es)
|
2013-06-26 |
2015-01-30 |
Abbvie Inc |
Carboxamidas primarias como inhibidores de btk
|
ES2686821T3
(es)
|
2013-06-28 |
2018-10-22 |
Beigene, Ltd. |
Compuestos tricíclicos fusionados de urea como inhibidores de Raf quinasa y/o dímero de Raf quinasa
|
WO2015002894A1
(en)
|
2013-07-02 |
2015-01-08 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
WO2015017533A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
CN105814057B
(zh)
|
2013-07-31 |
2019-05-03 |
默克专利有限公司 |
用作btk抑制剂的嘧啶、吡啶和吡嗪及其用途
|
EP3027601B1
(en)
|
2013-07-31 |
2017-10-25 |
Gilead Sciences, Inc. |
Syk inhibitors
|
US10028956B2
(en)
|
2013-08-02 |
2018-07-24 |
Ignyta, Inc. |
Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents
|
ES2661733T3
(es)
|
2013-08-12 |
2018-04-03 |
Taiho Pharmaceutical Co., Ltd. |
Compuesto de pirimidina condensado novedoso o sal del mismo
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
RU2016110874A
(ru)
|
2013-08-28 |
2017-10-04 |
Новартис Аг |
Комбинация ингибитора alk и ингибитора cdk для лечения клеточных пролиферативных заболеваний
|
CA2924362C
(en)
|
2013-09-18 |
2018-12-18 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Compound inhibiting activities of btk and/or jak3 kinases
|
WO2015039333A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2015039334A1
(en)
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
TN2016000094A1
(en)
|
2013-09-30 |
2017-07-05 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase.
|
JP6615752B2
(ja)
|
2013-09-30 |
2019-12-04 |
グアンジョウ・イノケア・ファーマ・テク・カンパニー・リミテッド |
Btkの置換ニコチンイミド阻害剤およびそれらの調製、ならびにがん、炎症および自己免疫疾患の治療における使用
|
JP5887028B2
(ja)
|
2013-10-16 |
2016-03-16 |
富士フイルム株式会社 |
含窒素複素環化合物の塩またはその結晶、医薬組成物およびflt3阻害剤
|
EP3060550B1
(en)
|
2013-10-21 |
2019-05-15 |
Merck Patent GmbH |
Heteroaryl compounds as btk inhibitors and uses thereof
|
JP6434506B2
(ja)
|
2013-10-21 |
2018-12-05 |
ジェノスコ |
置換ピリミジン化合物およびsyk阻害剤としてのそれらの使用
|
CN105683188B
(zh)
|
2013-10-25 |
2018-02-09 |
诺华股份有限公司 |
作为fgfr4抑制剂的稠环二环吡啶基衍生物
|
EP3061747B1
(en)
|
2013-10-25 |
2021-04-07 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof
|
EP3067356B1
(en)
|
2013-11-08 |
2018-07-04 |
ONO Pharmaceutical Co., Ltd. |
Pyrrolo pyrimidine derivative
|
CN104447640B
(zh)
|
2013-12-02 |
2016-07-13 |
北京键凯科技有限公司 |
3-呋喃基-2-氰基-2-丙烯酰胺衍生物及其制备方法、药物组合物和用途
|
JP6345786B2
(ja)
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|
US9067914B1
(en)
|
2013-12-10 |
2015-06-30 |
Genzyme Corporation |
Tropomyosin-related kinase (TRK) inhibitors
|
WO2015095445A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
WO2015094997A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
WO2015095099A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
EP3082811B1
(en)
|
2013-12-20 |
2020-01-15 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
US9670196B2
(en)
|
2013-12-20 |
2017-06-06 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
|
TWI662037B
(zh)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
脾酪胺酸激酶抑制劑
|
PL3087070T3
(pl)
|
2013-12-26 |
2018-03-30 |
Ignyta, Inc. |
Pochodne pirazolo[1,5-a]pirydyny i sposoby ich zastosowania
|
WO2015116485A1
(en)
|
2014-01-29 |
2015-08-06 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds as btk inhibitors
|
JP6162904B2
(ja)
|
2014-02-03 |
2017-07-12 |
カディラ ヘルスケア リミティド |
新規複素環式化合物
|
LT3103453T
(lt)
|
2014-02-04 |
2020-05-11 |
Astellas Pharma Inc. |
Vaisto kompozicija, apimanti diamino heterociklinį karboksamido junginį kaip aktyvų ingredientą
|
JP6348190B2
(ja)
|
2014-02-27 |
2018-06-27 |
ジアーンスゥ アセンテージ バイオメッド ディベロップメント インコーポレイティド |
未分化リンパ腫キナーゼ(alk)阻害剤としてのインドロキノロン化合物
|
EP3116506B1
(en)
|
2014-03-13 |
2019-04-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
MY185837A
(en)
|
2014-03-19 |
2021-06-12 |
Boehringer Ingelheim Int |
Heteroaryl syk inhibitors
|
MX2016012460A
(es)
|
2014-03-24 |
2017-05-04 |
Ab Science |
Derivados de oxazol sustituidos por diazaespiroalcanona como inhibidores de torosina quinasa de bazo.
|
WO2015143653A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143654A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
WO2015143652A1
(en)
|
2014-03-26 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
|
ES2715676T3
(es)
|
2014-03-27 |
2019-06-05 |
Janssen Pharmaceutica Nv |
Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirazina sustituidos y derivados de 5,6,7,8-tetrahidro-4h-pirazolo[1,5-a][1,4]diazepina como inhibidores de ros1
|
JP6527167B2
(ja)
|
2014-03-27 |
2019-06-05 |
ヤンセン ファーマシューティカ エヌ.ベー. |
ROS1阻害剤としての置換4,5,6,7−テトラヒドロ−ピラゾロ[1,5−a]ピリミジン誘導体および2,3−ジヒドロ−1H−イミダゾ[1,2−b]ピラゾール誘導体
|
CN106458914B
(zh)
|
2014-03-28 |
2020-01-14 |
常州捷凯医药科技有限公司 |
作为axl抑制剂的杂环化合物
|
CN105017256A
(zh)
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
CN105085474B
(zh)
|
2014-05-07 |
2018-05-18 |
北京赛林泰医药技术有限公司 |
鲁顿酪氨酸激酶抑制剂
|
SG11201608542YA
(en)
|
2014-05-14 |
2016-11-29 |
Nissan Chemical Ind Ltd |
Tricyclic compound and jak inhibitor
|
NZ727418A
(en)
|
2014-05-15 |
2023-03-31 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1h-pyrazol-5-yl)urea as a trka kinase inhibitor
|
AU2015266453C1
(en)
|
2014-05-30 |
2018-09-13 |
Shanghai Emerald Wellcares Pharmaceutical Co., Ltd |
Alk kinase inhibitor, and preparation method and use thereof
|
JP6622726B2
(ja)
|
2014-06-17 |
2019-12-18 |
コリア リサーチ インスティチュート オブ ケミカル テクノロジーKorea Research Institute Of Chemical Technology |
ピリミジン‐2,4‐ジアミン誘導体及びそれを有効成分として含有する抗癌用医薬組成物
|
EP3157921A1
(en)
|
2014-06-23 |
2017-04-26 |
Dr. Reddy's Laboratories Ltd. |
Substituted imidazo[1,2-a]pyridine compounds useful for the treatment of pain
|
TWI690525B
(zh)
|
2014-07-07 |
2020-04-11 |
日商第一三共股份有限公司 |
具有四氫吡喃基甲基之吡啶酮衍生物及其用途
|
TW201617074A
(zh)
|
2014-07-14 |
2016-05-16 |
吉李德科學股份有限公司 |
Syk(脾酪胺酸激酶)抑制劑
|
AU2015296215A1
(en)
|
2014-08-01 |
2017-03-23 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
JP6618120B2
(ja)
|
2014-08-06 |
2019-12-11 |
塩野義製薬株式会社 |
TrkA阻害活性を有する複素環および炭素環誘導体
|
NO2721710T3
(US07803786-20100928-C00028.png)
|
2014-08-21 |
2018-03-31 |
|
|
KR101710127B1
(ko)
|
2014-08-29 |
2017-02-27 |
한화제약주식회사 |
야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민
|
US20170281641A1
(en)
|
2014-09-03 |
2017-10-05 |
Genzyme Corporation |
CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS
|
CN105524068B
(zh)
|
2014-09-30 |
2017-11-24 |
上海海雁医药科技有限公司 |
氮杂双环衍生物、其制法与医药上的用途
|
EP3200786B1
(en)
|
2014-10-03 |
2019-08-28 |
Novartis AG |
Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
|
US10253023B2
(en)
|
2014-10-06 |
2019-04-09 |
Merck Patent Gmbh |
Heteroaryl compounds as BTK inhibitors and uses thereof
|
CN111170999B
(zh)
|
2014-10-11 |
2023-06-30 |
上海翰森生物医药科技有限公司 |
Egfr抑制剂及其制备和应用
|
EA031614B1
(ru)
|
2014-10-24 |
2019-01-31 |
Бристол-Майерс Сквибб Компани |
Трициклические атропоизомерные соединения
|
CN107148421A
(zh)
|
2014-10-30 |
2017-09-08 |
桑多斯股份公司 |
活性丙烯酰胺类化合物
|
CN105085489B
(zh)
|
2014-11-05 |
2019-03-01 |
益方生物科技(上海)有限公司 |
嘧啶或吡啶类化合物、其制备方法和医药用途
|
US9862712B2
(en)
|
2014-11-20 |
2018-01-09 |
Council Of Scientific & Industrial Research |
Benzimidazole based EGFR inhibitors
|
CN105601573B
(zh)
|
2014-11-24 |
2021-07-02 |
中国科学院上海药物研究所 |
2-氨基嘧啶类化合物及其药物组合物和应用
|
EP3229800A2
(en)
|
2014-12-11 |
2017-10-18 |
Bayer Pharma Aktiengesellschaft |
Use of pan fgfr inhibitors and method of identifying patients with cancer eligible for treatment with a pan fgfr inhibitor
|
EP3233829B1
(en)
|
2014-12-18 |
2019-08-14 |
Pfizer Inc |
Pyrimidine and triazine derivatives and their use as axl inhibitors
|
JP6708130B2
(ja)
|
2014-12-25 |
2020-06-10 |
小野薬品工業株式会社 |
キノリン誘導体
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
WO2016106627A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
CN104530063B
(zh)
|
2015-01-13 |
2017-01-18 |
北京赛特明强医药科技有限公司 |
喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
|
CN105837576B
(zh)
|
2015-01-14 |
2019-03-26 |
湖北生物医药产业技术研究院有限公司 |
Btk抑制剂
|
CA2979425C
(en)
|
2015-01-20 |
2020-04-14 |
Wuxi Fortune Pharmaceutical Co., Ltd |
Jak inhibitor
|
US10336723B2
(en)
|
2015-01-23 |
2019-07-02 |
Gvk Biosciences Private Limited |
Inhibitors of TrkA kinase
|
AU2016214923A1
(en)
|
2015-02-03 |
2017-08-24 |
Trillium Therapeutics Inc. |
Novel fluorinated derivatives as EGFR inhibitors useful for treating cancers
|
WO2016125186A1
(en)
|
2015-02-03 |
2016-08-11 |
Council Of Scientific & Industrial Research |
Novel flavone based egfr inhibitors and process for preparation thereof
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
WO2016161572A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
WO2016161570A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Azacarbazole btk inhibitors
|
ES2807851T3
(es)
|
2015-04-14 |
2021-02-24 |
Qurient Co Ltd |
Derivados de quinolina como inhibidores de RTK de TAM
|
ES2734048T3
(es)
|
2015-04-29 |
2019-12-04 |
Wuxi Fortune Pharmaceutical Co Ltd |
Inhibidores de Janus cinasas (JAK)
|
CN107667108B
(zh)
|
2015-05-28 |
2020-05-12 |
施万生物制药研发Ip有限责任公司 |
作为jak激酶抑制剂的萘啶化合物
|
PL3305788T3
(pl)
|
2015-05-29 |
2021-03-08 |
Wuxi Fortune Pharmaceutical Co., Ltd |
Inhibitor kinazy janusowej
|
EP3310776A4
(en)
|
2015-06-02 |
2019-01-16 |
Pharmacyclics LLC |
INHIBITORS OF BRUTON TYROSINE KINASE
|
LT3303334T
(lt)
|
2015-06-03 |
2021-07-12 |
Principia Biopharma Inc. |
Tirozinkinazės inhibitoriai
|
WO2016192074A1
(en)
|
2015-06-04 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
MA42242A
(fr)
|
2015-06-24 |
2018-05-02 |
Principia Biopharma Inc |
Inhibiteurs de la tyrosine kinase
|
WO2017006953A1
(ja)
|
2015-07-07 |
2017-01-12 |
塩野義製薬株式会社 |
TrkA阻害活性を有する複素環誘導体
|
AU2016289061B2
(en)
|
2015-07-07 |
2020-07-09 |
Japan Tobacco Inc. |
Method for producing 7H-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
|
JP6853234B2
(ja)
|
2015-07-09 |
2021-03-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Btk阻害剤としてのピリミジン誘導体及びその使用
|
US10329277B2
(en)
|
2015-07-16 |
2019-06-25 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity
|
SI3322706T1
(sl)
|
2015-07-16 |
2021-04-30 |
Array Biopharma, Inc. |
Substituirane pirazolo(1,5-A)piridinske spojine kot zaviralci ret-kinaze
|
AU2016296877B2
(en)
|
2015-07-20 |
2020-09-17 |
Dana-Farber Cancer Institute, Inc. |
Novel pyrimidines as EGFR inhibitors and methods of treating disorders
|
LT3325623T
(lt)
*
|
2015-07-23 |
2019-10-25 |
Inst Curie |
Dbait molekulės ir parp inhibitorių derinio panaudojimas vėžiui gydyti
|
EP3327014A4
(en)
|
2015-07-24 |
2019-01-02 |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Egfr inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
CN106467541B
(zh)
|
2015-08-18 |
2019-04-05 |
暨南大学 |
取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用
|
CN107406431B
(zh)
|
2015-08-20 |
2020-06-26 |
上海昂睿医药技术有限公司 |
吲哚类衍生物及其制备方法和其在医药上的用途
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
ES2929528T3
(es)
|
2015-09-16 |
2022-11-29 |
Loxo Oncology Inc |
Derivados de pirazolopirimidina como inhibidores de BTK para el tratamiento del cáncer
|
EP3144307A1
(en)
|
2015-09-18 |
2017-03-22 |
AB Science |
Novel oxazole derivatives that inhibit syk
|
CN106554347B
(zh)
|
2015-09-25 |
2020-10-30 |
浙江博生医药有限公司 |
Egfr激酶抑制剂及其制备方法和应用
|
US10526309B2
(en)
|
2015-10-02 |
2020-01-07 |
The University Of North Carolina At Chapel Hill |
Pan-TAM inhibitors and Mer/Axl dual inhibitors
|
EP3414234B1
(en)
|
2015-10-14 |
2022-06-29 |
Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|
WO2017070708A1
(en)
|
2015-10-23 |
2017-04-27 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2h)-one compounds as inhibitors of fgfr tyrosine kinases
|
BR112018008966B1
(pt)
|
2015-11-03 |
2023-05-02 |
Theravance Biopharma R&D Ip, Llc |
Compostos inibidores de jak quinase, hidrato cristalino, composição farmacêutica, processos, método de preparação do hidrato cristalino e uso dos referidos compostos e hidrato cristalino no tratamento de doença respiratória
|
CN106699743B
(zh)
|
2015-11-05 |
2020-06-12 |
湖北生物医药产业技术研究院有限公司 |
嘧啶类衍生物及其用途
|
EP3865485A1
(en)
|
2015-11-06 |
2021-08-18 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of bruton's tyrosine kinase
|
US10370379B2
(en)
|
2015-11-19 |
2019-08-06 |
Blueprint Medicines Corporation |
Compounds and compositions useful for treating disorders related to NTRK
|
NZ742574A
(en)
|
2015-11-24 |
2018-11-30 |
Theravance Biopharma R&D Ip Llc |
Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease
|
JP6860267B2
(ja)
|
2015-12-11 |
2021-04-14 |
シチュアン ケルン−バイオテック バイオファーマシューティカル カンパニー リミテッド |
アゼチジン誘導体、その調製方法、及びその使用
|
LT3390390T
(lt)
|
2015-12-16 |
2021-11-25 |
Boehringer Ingelheim International Gmbh |
Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
|
CN106928231B
(zh)
|
2015-12-31 |
2021-06-01 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的egfr野生型和突变型的激酶抑制剂
|
CN108779079A
(zh)
|
2016-01-06 |
2018-11-09 |
特里乌姆治疗公司 |
作为egfr抑制剂的新的氟化喹唑啉衍生物
|
SG11201805869XA
(en)
|
2016-01-11 |
2018-08-30 |
Merck Patent Gmbh |
Quinolin-2-one derivatives
|
WO2017123695A1
(en)
|
2016-01-13 |
2017-07-20 |
Boehringer Ingelheim International Gmbh |
Isoquinolones as btk inhibitors
|
MX2018008815A
(es)
|
2016-01-21 |
2019-03-28 |
Zibo Biopolar Changsheng Pharmaceutical Co Ltd |
Inhibidores de tirosina quinasa de bruton.
|
ES2877200T3
(es)
|
2016-01-26 |
2021-11-16 |
Hangzhou Bangshun Pharmaceutical Co Ltd |
Derivado azacíclico de cinco miembros de pirrolopirimidina y aplicación del mismo
|
CN107021963A
(zh)
|
2016-01-29 |
2017-08-08 |
北京诺诚健华医药科技有限公司 |
吡唑稠环类衍生物、其制备方法及其在治疗癌症、炎症和免疫性疾病上的应用
|
WO2017135399A1
(ja)
|
2016-02-04 |
2017-08-10 |
塩野義製薬株式会社 |
TrkA阻害活性を有する含窒素複素環および炭素環誘導体
|
CA3014090A1
(en)
|
2016-02-19 |
2017-08-24 |
Jiangsu Hengrui Medicine Co., Ltd. |
Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof
|
AU2017222908B2
(en)
|
2016-02-23 |
2021-02-04 |
Taiho Pharmaceutical Co., Ltd. |
Novel condensed pyrimidine compound or salt thereof
|
EP3423068A1
(en)
*
|
2016-03-01 |
2019-01-09 |
Onxeo |
Treatment of cancer by systemic administration of dbait molecules
|
CN107151249B
(zh)
|
2016-03-04 |
2020-08-14 |
华东理工大学 |
作为flt3抑制剂的蝶啶酮衍生物及应用
|
AR107912A1
(es)
|
2016-03-17 |
2018-06-28 |
Blueprint Medicines Corp |
Inhibidores de ret
|
CN107286077B
(zh)
|
2016-04-01 |
2021-04-02 |
合肥中科普瑞昇生物医药科技有限公司 |
一种选择性的c-kit激酶抑制剂
|
CA3021558A1
(en)
|
2016-04-29 |
2017-11-02 |
X-Chem, Inc. |
Covalent btk inhibitors and uses thereof
|
KR20220130249A
(ko)
|
2016-05-26 |
2022-09-26 |
리커리엄 아이피 홀딩스, 엘엘씨 |
Egfr 억제제 화합물
|
CN107759600A
(zh)
|
2016-06-16 |
2018-03-06 |
正大天晴药业集团股份有限公司 |
作为jak抑制剂的吡咯并嘧啶化合物的结晶
|
JP2019520382A
(ja)
|
2016-06-27 |
2019-07-18 |
杭州雷索薬業有限公司Hangzhou Rex Pharmaceutical Co., Ltd |
ベンゾフランピラゾールアミン類プロテインキナーゼ阻害薬
|
WO2018002958A1
(en)
|
2016-06-30 |
2018-01-04 |
Sun Pharma Advanced Research Company Limited |
Novel hydrazide containing compounds as btk inhibitors
|
CA3032795C
(en)
|
2016-06-30 |
2021-06-22 |
Yubin LV |
Imidazopyridinamine phenyl derivative and use thereof
|
JP6726773B2
(ja)
|
2016-07-07 |
2020-07-22 |
デウン ファーマシューティカル カンパニー リミテッド |
新規な4−アミノピラゾロ[3,4−d]ピリミジニルアザビシクロ誘導体およびこれを含む薬学組成物
|
CN107619388A
(zh)
|
2016-07-13 |
2018-01-23 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
US10227329B2
(en)
|
2016-07-22 |
2019-03-12 |
Blueprint Medicines Corporation |
Compounds useful for treating disorders related to RET
|
WO2018022761A1
(en)
|
2016-07-27 |
2018-02-01 |
Blueprint Medicines Corporation |
Substituted cyclopentane-amides for treating disorders related to ret
|
CN107698593A
(zh)
|
2016-08-09 |
2018-02-16 |
南京天印健华医药科技有限公司 |
作为fgfr抑制剂的杂环化合物
|
EP3500569B1
(en)
|
2016-08-16 |
2022-05-18 |
Merck Patent GmbH |
2-oxo-imidazopyridines as reversible btk inhibitors and uses thereof
|
WO2018044767A2
(en)
|
2016-08-29 |
2018-03-08 |
The Regents Of The University Of Michigan |
Aminopyrimidines as alk inhibitors
|
TW201822764A
(zh)
|
2016-09-14 |
2018-07-01 |
美商基利科學股份有限公司 |
Syk抑制劑
|
EP3512519A1
(en)
|
2016-09-14 |
2019-07-24 |
Gilead Sciences, Inc. |
Syk inhibitors
|
CN107840846B
(zh)
|
2016-09-19 |
2020-11-24 |
郑州泰基鸿诺医药股份有限公司 |
一种含嘧啶环的化合物、egfr抑制剂及其应用
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
JP2018052878A
(ja)
|
2016-09-29 |
2018-04-05 |
第一三共株式会社 |
ピリジン化合物
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
WO2018079759A1
(ja)
|
2016-10-31 |
2018-05-03 |
塩野義製薬株式会社 |
TrkA阻害活性を有する縮合複素環および縮合炭素環誘導体
|
KR102686957B1
(ko)
|
2016-11-08 |
2024-07-22 |
주식회사 대웅제약 |
신규한 피롤로피리미딘 유도체 및 이를 포함하는 약학적 조성물
|
WO2018090792A1
(zh)
|
2016-11-15 |
2018-05-24 |
杭州和正医药有限公司 |
一种选择性布鲁顿酪氨酸激酶抑制剂及其应用
|
CN110191886A
(zh)
|
2016-11-18 |
2019-08-30 |
密执安大学评议会 |
5,6-二氢-11h-吲哚并[2,3-b]喹啉-11-酮作为alk抑制剂
|
CN108101905A
(zh)
|
2016-11-24 |
2018-06-01 |
中国科学院上海药物研究所 |
嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途
|
US11142535B2
(en)
|
2016-12-12 |
2021-10-12 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor
|
WO2018108064A1
(zh)
|
2016-12-13 |
2018-06-21 |
南京明德新药研发股份有限公司 |
作为第四代egfr激酶抑制剂的螺环芳基磷氧化合物
|
WO2018112140A1
(en)
|
2016-12-15 |
2018-06-21 |
Ariad Pharmaceuticals, Inc. |
Benzimidazole compounds as c-kit inhibitors
|
KR102594476B1
(ko)
|
2016-12-15 |
2023-10-27 |
어리어드 파마슈티칼스, 인코포레이티드 |
C-kit 억제제로서의 아미노티아졸 화합물
|
CN108250200A
(zh)
|
2016-12-28 |
2018-07-06 |
中国科学院上海药物研究所 |
一种具有Axl抑制活性的化合物及其制备和应用
|
US11130761B2
(en)
|
2016-12-29 |
2021-09-28 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors
|
JP7053665B2
(ja)
|
2016-12-30 |
2022-04-12 |
南京明徳新薬研発有限公司 |
Egfr阻害としてのキナゾリン系化合物
|
CN108276410B
(zh)
|
2017-01-06 |
2021-12-10 |
首药控股(北京)股份有限公司 |
一种间变性淋巴瘤激酶抑制剂及其制备方法和用途
|
CN115844877B
(zh)
|
2017-01-10 |
2024-07-23 |
浙江嘉驰医药开发有限公司 |
拉索昔芬调节膜结合雌激素信号的应用及治疗癌症的方法
|
WO2018136663A1
(en)
|
2017-01-18 |
2018-07-26 |
Array Biopharma, Inc. |
Ret inhibitors
|
CN110267960B
(zh)
|
2017-01-18 |
2022-04-26 |
阿雷生物药品公司 |
作为RET激酶抑制剂的取代的吡唑并[1,5-a]吡嗪化合物
|
CN106831787B
(zh)
|
2017-01-20 |
2018-10-23 |
成都倍特药业有限公司 |
用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用
|
WO2018145525A1
(zh)
|
2017-02-08 |
2018-08-16 |
中国医药研究开发中心有限公司 |
吡咯并芳杂环类化合物及其制备方法和医药用途
|
WO2018153293A1
(zh)
|
2017-02-27 |
2018-08-30 |
北京赛特明强医药科技有限公司 |
二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
|
KR20190126344A
(ko)
|
2017-02-27 |
2019-11-11 |
베타 파머수티컬 컴퍼니 리미티드 |
Fgfr 억제제 및 이의 용도
|
US10464923B2
(en)
|
2017-02-27 |
2019-11-05 |
Merck Patent Gmbh |
Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
EP3601264A4
(en)
|
2017-03-22 |
2021-03-24 |
Xibin Liao |
INHIBITORS OF BRUTON TYROSIN KINASE
|
WO2018187355A1
(en)
|
2017-04-03 |
2018-10-11 |
Health Research Inc. |
Met kinase inhibitors and uses therefor
|
CN108727382B
(zh)
|
2017-04-19 |
2022-07-19 |
华东理工大学 |
作为btk抑制剂的杂环化合物及其应用
|
CN108721298A
(zh)
|
2017-04-19 |
2018-11-02 |
华东理工大学 |
作为布鲁顿酪氨酸激酶抑制剂的嘧啶并杂环化合物及其应用
|
CN107043366B
(zh)
|
2017-04-25 |
2020-05-26 |
中国药科大学 |
4-氨基嘧啶类化合物、其制备方法及医药用途
|
EP3617195B1
(en)
|
2017-04-27 |
2024-08-28 |
Mochida Pharmaceutical Co., Ltd. |
Novel tetrahydronaphthyl urea derivatives as inhibitors of tropomyosin receptor kinase a for the treatment of pain
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
WO2018208132A1
(en)
|
2017-05-12 |
2018-11-15 |
Korea Research Institute Of Chemical Technology |
Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient
|
WO2018215390A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
TW201902896A
(zh)
|
2017-05-22 |
2019-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療化合物及組合物及其使用方法
|
CN107176954B
(zh)
|
2017-06-02 |
2019-01-11 |
无锡双良生物科技有限公司 |
一种egfr抑制剂的药用盐及其晶型、制备方法和应用
|
JP7299167B2
(ja)
|
2017-06-14 |
2023-06-27 |
チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド |
Syk阻害薬及びその使用方法
|
CN109111446B
(zh)
|
2017-06-22 |
2021-11-30 |
上海度德医药科技有限公司 |
一种具有药物活性的杂芳基化合物
|
BR112019027676A2
(pt)
|
2017-06-27 |
2020-09-15 |
Janssen Pharmaceutica Nv |
compostos de quinolinona
|
EP3648753A4
(en)
|
2017-07-05 |
2021-03-17 |
CS Pharmatech Limited |
SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF EGFR TYROSINE KINASE
|
US11377449B2
(en)
|
2017-08-12 |
2022-07-05 |
Beigene, Ltd. |
BTK inhibitors with improved dual selectivity
|
WO2019034075A1
(zh)
|
2017-08-15 |
2019-02-21 |
南京明德新药研发股份有限公司 |
Fgfr和egfr抑制剂
|
EP3670513B1
(en)
|
2017-08-15 |
2023-09-20 |
CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Fgfr inhibitor and medical application thereof
|
WO2019034538A1
(en)
|
2017-08-18 |
2019-02-21 |
Universität Regensburg |
SYNTHESIS, PHARMACOLOGY AND USE OF NEW FMS FLT3 TYROSINE KINASE 3 (FLT3) SELECTIVE INHIBITORS
|
CN109400610A
(zh)
|
2017-08-18 |
2019-03-01 |
浙江海正药业股份有限公司 |
吡咯并三嗪类衍生物、其制备方法及其在医药上的用途
|
KR20200041954A
(ko)
|
2017-08-18 |
2020-04-22 |
북경한미약품 유한공사 |
화합물, 이의 약제학적 조성물, 및 이의 용도 및 응용
|